Didier Hoch

Didier Hoch

68 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Didier Hoch is the founder of Big Booster'S, which was founded in 2014.
He is currently the Co-Chairman of Underground Charity Foundation, Chairman of PHAXIAM Therapeutics SA since 2023, and Independent Director of OSE Immunotherapeutics SA since 2016.
He also holds positions as Director at Fondation Universite Grenoble Alpes, Goliver Therapeutics, and Myasterix.
Dr. Hoch has previously held positions as Chairman & Chief Executive Officer at Pherecydes Pharma SA in 2022, Chairman at MSD Vaccines Ltd.
and Sanofi Pasteur from 2000 to 2010, Non-Executive Chairman at Pevion Biotech AG from 2011 to 2013, Chairman at BioVision from 2013 to 2018, Chairman at Fondation pour l’Université de Lyon from 2014 to 2018, Director at DBV Technologies SA from 2012 to 2016, Independent Director at ERYTech Pharma SA and Effimune SA, Independent Director at Germitec SA from 2014 to 2019, Vice President at Rhone Poulenc Rorer from 2000 to 2009, President at European Vaccine Manufacturers from 2009 to 2010, Member-Supervisory Board at Genticel SA from 2011 to 2017, President-Life Science Health Committee at Mouvement des Entreprises de France, and Vice President-Africa & Middle East Region at Aventis Pharma International SAS.
Dr. Hoch's education includes an undergraduate degree from ESCP Europe Campus Paris and a doctorate from the University of Lyon in 1984.

Aktive Positionen von Didier Hoch

UnternehmenPositionBeginn
OSE IMMUNOTHERAPEUTICS Director/Board Member 31.05.2016
PHAXIAM THERAPEUTICS S.A. Chairman 23.06.2023
Goliver Therapeutics Director/Board Member -
Fondation Universite Grenoble Alpes Director/Board Member -
Underground Charity Foundation Chairman 01.01.2018
Myasterix Director/Board Member -
Alle aktiven Positionen von Didier Hoch

Ehemalige bekannte Positionen von Didier Hoch

UnternehmenPositionEnde
Director/Board Member 01.01.2019
Fondation pour l’Université de Lyon Chairman 02.01.2018
Founder 01.01.2018
░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Didier Hoch im Detail an

Ausbildung von Didier Hoch

ESCP Europe Campus Paris Undergraduate Degree
University of Lyon Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Didier Hoch im Detail an

Beziehungen

95

Beziehungen ersten Grades

24

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
DBV TECHNOLOGIES

Health Technology

OSE IMMUNOTHERAPEUTICS

Health Technology

PHAXIAM THERAPEUTICS S.A.

Health Technology

Private Unternehmen19

Process Industries

Health Technology

Health Technology

Health Technology

Health Technology

European Vaccine Manufacturers

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

BioVision

Myasterix

Fondation pour l’Université de Lyon

Aventis Pharma International SAS

Underground Charity Foundation

Fondation Universite Grenoble Alpes

Goliver Therapeutics

Commercial Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Didier Hoch